To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

A stop-codon of the phosp… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

A stop-codon of the phosphodiesterase 11A gene is associated with elevated blood pressure and measures of obesity

Journal article
Authors T. Ohlsson
A. Lindgren
G. Engstrom
Christina Jern
Olof Melander
Published in Journal of Hypertension
Volume 34
Issue 3
Pages 445-451
ISSN 0263-6352
Publication year 2016
Published at Institute of Biomedicine, Department of Medical and Clinical Genetics
Pages 445-451
Language en
Links dx.doi.org/10.1097/hjh.000000000000...
Keywords blood pressure, Cushing's syndrome, illumina exome chip, stop-codon, stroke, genome-wide association, epithelial sodium-channel, cardiovascular-disease, cushings-syndrome, complex traits, hypertension, mutations, risk, heritability, phenotypes, Cardiovascular System & Cardiology
Subject categories Cardiac and Cardiovascular Systems

Abstract

Objective:To identify stop-codon variants associated with blood pressure (BP).Methods:Illumina exome chip was genotyped in 5453 individuals of the population-based Malmo Diet and Cancer Study. We compared BP levels between carriers and noncarriers of all stop-codon variants found in at least 10 individuals and characterized these further based on literature evidence of functionality. Next, the association to ischemic stroke was evaluated in 2278 cases of ischemic stroke and 5969 controls.Results:We identified 19 stop-codon variants with nominally significant BP associations (P<0.05). One of these, located in the phosphodiesterase 11A (PDE11A) gene (R307X), has previously been reported to cause loss of PDE11A function and Cushing's syndrome in female carriers. In the Malmo Diet and Cancer Study, 1% of the population carried R307X and had age and sex-adjusted (mean, 95% confidence interval) 5.0, 0.29-9.7 (P=0.038), and 3.3, 0.83-5.7 (P=0.009) mmHg higher SBP and DBP than noncarriers and also significantly higher waist circumference and BMI. Among females, carriers of the R307X had age adjusted 8.3, 2.3-14 (P=0.006) and 4.7, 1.7-7.7 (P=0.002) mmHg higher SBP and DBP, 4.3, 0.84-7.8 (P=0.015)cm higher waist circumference and 1.7, 0.30-3.1 (P=0.018)kg/m(2) higher BMI. In addition, carriers of the R307X mutation had an odds ratio of ischemic stroke of 1.73 (95% confidence interval 1.06-2.82); P=0.028.Conclusion:One percent of the Swedish population carries a PDE11A loss-of-function mutation associated with elevated BP, abdominal obesity, and risk of ischemic stroke.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?